Interferon-induced changes in the susceptibility of murine and human lymphoma cells to natural cytotoxic lymphocytes
- PMID: 6585352
Interferon-induced changes in the susceptibility of murine and human lymphoma cells to natural cytotoxic lymphocytes
Abstract
Mouse YAC-1 and human K562 leukemic cells were treated in vitro with fibroblast interferon (IF) and tested for their susceptibility to NK effector lymphocytes. In both cases a decrease in target susceptibility was induced by the IF treatment. "Cold" competition experiments confirmed that loss or masking of NK target structures occurred in IF-pretreated cells. In fact, when radio-labeled untreated cells were used as targets, IF-pretreated leukemias produced inhibitory effects lower than those mediated by intact cells. However when IF-pretreated targets were used, cold cells either intact or preincubated with IF gave similar competitive effects. These data suggest that IF modulates differentially distinct subsets of NK target structures.
Similar articles
-
Interferon and butyrate treatment leads to a decreased sensitivity of NK target cells to lysis by homologous but not by heterologous effector cells.Nat Immun Cell Growth Regul. 1986;5(4):211-20. Nat Immun Cell Growth Regul. 1986. PMID: 3095635
-
Antileukemia activity of a natural killer cell line against human leukemias.Clin Cancer Res. 1998 Nov;4(11):2859-68. Clin Cancer Res. 1998. PMID: 9829753
-
Resistance to natural killer cell-mediated cytolysis by a pleiotropic drug-resistant human erythroleukemia (K562-R) cell line.Cancer Res. 1986 Sep;46(9):4511-5. Cancer Res. 1986. PMID: 2425955
-
Rat natural killer cell activity against lymphoid and nonlymphoid tumor cells and normal rat cell lines.Cancer Res. 1983 Sep;43(9):4248-52. Cancer Res. 1983. PMID: 6871862
-
Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.J Immunol. 1984 Feb;132(2):936-44. J Immunol. 1984. PMID: 6690624
Cited by
-
Histocompatibility antigens and natural killer susceptibility.Immunol Res. 1992;11(2):133-40. doi: 10.1007/BF02918618. Immunol Res. 1992. PMID: 1431422 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous